MHM Magazine

ADHD is the most common psychiatric disorder in children, affecting approximately 1 in 20, and follows about 65% of them into adulthood, affecting about 1 million adults in South Africa. If left untreated, the condition can hamper sufferers’ educational performance, self-esteem, relationships, and work productivity, and lead to an increased risk of other psychiatric disorders, reduced social functioning, delinquency, and substance abuse. By not using the correct medication, children can fall behind in school, struggle to manage their emotions and relationships, see a rise in depression, anxiety and an increase in impulsive behaviour that could cause harm to themselves or others. Adults, if untreated, are also at risk as their interpersonal and work functioning may be affected, and the risk for developing comorbid mental health disorders, increases. Since the publication of the South African management guidelines for adult ADHD (Schoeman & Liebenberg, 2016), many generics and new formulations of available substances, as well as new molecules have entered the South African market. Please consult the guidelines which emphasise the importance of a comprehensive diagnostic assessment, holistic treatment approach, and individualised care. By Professor Renata Schoeman Psychiatrist Goldilocks and the Bear Foundation Cape Town MEDICAL MANAGEMENT OF ADHD: THE LATEST TREATMENT AND MEDICATION OPTIONS FOR PATIENTS GENERAL APPROACH 6 | MENTAL HEALTH MATTERS | 2024 | Issue 1 MHM